ClinicalTrials.gg
CompletedNCT06372860Updated Nov 17, 2026Results posted

DPP Feasibility Study of Breastfeeding - eMOMS 2.0

An interventional study of Diabetes Prevention Program and Breastfeeding in Overweight or Obesity and Pregnancy, sponsored by University of Kansas Medical Center. Completed at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.

Primary conditionObesityRegistry: OverweightReclassifiedWhy we changed it
Registry
Overweight — the first condition term the registry derived for this study.
ClinicalTrials.gg
Obesity
Why
  1. The study's listed conditions name Obesity, a narrower term within Overweight.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University of Kansas Medical Center · Not applicable, Interventional, and Treatment

How we know

Updated Nov 17, 2026Results postedPrimary outcomes revisedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
43
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 32 studies in Obesity by University of Kansas Medical Center — 9 open to participants now, 9 under way, none of them phase 3. Obesity · University of Kansas Medical Center.

Enrollment
16th of 29
43 · median 60
Started
2024
with 4 others
No phase
28 of 32
6 open now
Registered
24th of 32
by date

Among the 32 studies in Obesity by University of Kansas Medical Center, this one is the 16th largest by enrollment of the 29 interventional ones that give a count, is one of 5 that started in 2024, is one of 28 with no phase, and was the 24th registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

9 of the 32 studies in Obesity by University of Kansas Medical Center are open now, in 1 country. Recruiting first, the newest first:

4 more — sign in →

By country, each count listing its studies:

All 9 open studies →

Where they have run

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 32 studies in Obesity by University of Kansas Medical Center, or all of them as a file.
02

Study summary

The purpose of this study is to investigate the impact of a comprehensive intervention that combines breastfeeding support with a diabetes prevention-based program (DPP) on postpartum weight retention and lactation duration among women with pre-pregnancy overweight or obesity. This intervention, named eMOMS, is delivered by a certified health coach via a mobile health (mHealth) application.

Read the detailed description

This study is a randomized controlled trial designed to determine the feasibility and efficacy of a combined breastfeeding, diabetes prevention-based program (DPP) in a cohort of overweight or obese women to be followed during pregnancy through 3 months postpartum. The trial will have two study arms: DPP + breastfeeding (Tx1) and Usual Care (Tx2).

Aim 1: Measure weight loss and duration of lactation through 3 months postpartum among target population. To accomplish this, we will measure pre-pregnancy weight, weight at study entry, weight immediately prior to and after delivery, and weight at specific postpartum time points. Lactation and infant feeding practices will be measured at similar postpartum time points. Aim 2: Quantify interest in use of the DPP-lactation mobile health (mHealth) application among target population. To accomplish this, we will: (1) measure research engagement including rates of screening and recruitment among users, especially rural and racially/ethnically diverse women; and (2) evaluate intervention uptake, delivery, and adherence via tracking/measuring use of the mHealth app.

03

Conditions studied

  • Overweight or Obesity
  • Pregnancy

Browse trials for

Keywords

  • diabetes prevention
  • breastfeeding
  • lactation support
  • prediabetes
04

In context

Obesity Reclassified

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

This study's enrollment of 43 is below the median of 67 across 9,043 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

University of Kansas Medical Center is the lead sponsor of 493 studies on the registry; 111 are open to participants now.

Of its 38 completed or terminated interventional studies of FDA-regulated products, 24 (63%) have results posted.

Compared within Obesity, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Overweight. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pregnant
  • In second trimester or early third trimester
  • >/= 25 and \< 35
  • At least 18 years old or older
  • Able to read and understand English
  • Able to learn and use a video platform

Exclusion criteria

Exclusion Criteria:

  • Complications related to pregnancy that require emergency care
  • Thyroid disease
  • Multiple gestation
  • Substance abuse within last 3 years
  • Assisted reproductive technology (ART)-related pregnancy
  • Current smoker
  • Prior bariatric surgery
  • In weight-loss program within 3 months of conception
  • >/= 35
  • Unable to attend intervention/ follow-up visits
  • Unwilling to self-monitor data collection
  • Unable to complete intervention
  • Presence of any condition that limits walking
  • Presence of any condition that limits following diet recommendations
  • Pregnancies complicated with fetuses diagnosed with lethal malformations/conditions
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

06

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
43 participants (actual)

Study arms

  • Active comparator
    DPP + Breastfeeding (Tx1)

    Patients randomized to Tx1 will receive education in the Diabetes Prevention Program (DPP) and intensive breastfeeding education and support. Ante- and postpartum education includes access to the mHealth app and individualized 1-on-1 health coaching. Phase I is delivered antepartum and includes: four (4) 1-hour DPP-based educational sessions and six (6) 20-minute educational videos on lactation. Phase II is delivered postpartum and includes: in-hospital lactation support and two (2) 1-hour DPP-based educational sessions. Participants will continue to receive individualized 1-on-1 health coaching through 3 months postpartum.

    Behavioral: Diabetes Prevention Program · Behavioral: Breastfeeding · Behavioral: Usual Care

  • Placebo comparator
    Usual Care

    Usual care is described as obstetrical care that pregnant women with normal BMI receive and that is provided by their provider. There will not be any antepartum education or 1-on-1 health coaching. Postpartum education will only include usual care in-hospital lactation support. There will not be any other education nor 1-on-1 support.

    Behavioral: Usual Care

Interventions

  • BehavioralDiabetes Prevention Program

    The intervention will be administered by professionally trained, certified health coaches. Phase I consists of four 1-hour DPP-based sessions to be completed during pregnancy. Each session will be pre-recorded and archived on a secure, private mHealth application. Participants will be asked to complete each session on their own time. A health coach will follow up weekly via phone to check on progress and will work with the participant 1-on-1, if needed. Phase I will be completed by week 36 of pregnancy. Prior to delivery, participants are invited to a virtual focus group about their experiences. Phase II consists of two 1-hour DPP-based sessions to be completed after delivery. Each session will be pre-recorded and archived on the same mHealth application. Participants will begin Phase II within 1 week of delivery with the same health coach. Phase II will be completed by week 12 postpartum. Upon completion, participants are invited to a virtual focus group about their experiences.

  • BehavioralBreastfeeding

    Phase I also consists of six (6) breastfeeding videos that are pre-recorded into 15-20 minute sessions and will be available on the mHealth application. Participants will have access to the first 2 sessions by week 28 of pregnancy and need to complete the remaining 4 sessions by week 36 of pregnancy. Each session is taught by an International Board Certified Lactation Consultant (IBCLC). Participants will receive 1-on-1 lactation support by the same DPP health coach. The health coach is a professionally trained Certified Breastfeeding Specialist (CBS). She will assist participants with any questions related to lactation. If the health coach is unable to help with a specific issue, she will contact the IBCLC-of-record, who will provide assistance to the health coach only. If the health coach or IBCLC deems additional care necessary, the participant will be referred to their primary care physician. The IBCLC will not have direct contact with the study participants.

  • BehavioralUsual Care

    Participants will receive regular prenatal care provided by their physician. At delivery, all participants will receive some type of lactation support in the hospital.

07

What researchers measure

Primary outcomes

  1. Change in Weight

    The study team measured maternal weight at baseline, at delivery, and at 3 months postpartum to allow for meaningful comparisons of weight change among study arms.

    Time frame: At baseline and at delivery through 3 months postpartum

  2. Maternal Weight

    The study team measured maternal weight at baseline, at delivery, and at 3 months postpartum to allow for meaningful comparisons of weight change among study arms.

    Time frame: At baseline and at delivery through 3 months postpartum

  3. Duration of Breastfeeding and Supplementation

    The study team measured duration of breastfeeding and supplementation at day 3 postpartum and at specific timepoints through 3 months postpartum. Breastfeeding is defined as the feeding of human milk. The definition of "Exclusive Breastfeeding" is aligned with the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) and is as follows: the infant is fed only human milk and no other foods or fluids, not even water, except for oral rehydration solutions or drops/syrups of vitamins, minerals, or medicines. "Any Breastfeeding" is defined as the feeding of human milk supplemented with formula, water, etc. "Formula Only" is defined as the feeding of formula exclusively and no human milk.

    Time frame: At day 3, week 6, and 3 months postpartum.

Secondary outcomes

  1. Enrollment

    To assess recruitment and enrollment rates, the study team tracked the number of potential participants contacted/screened versus the number of participants who were eligible to enroll and the number of participants who consented to enroll in the study.

    Time frame: This will occur between day 1 of the first participant screened to the study participant being randomized to one of two study arms.

  2. mHealth Application Engagement

    To assess intervention uptake, the study team tracked the number of calls engaging with the mobile health app and with the health coach.

    Time frame: At 3 months postpartum.

  3. mHealth Application Engagement (2)

    To assess intervention uptake, the study team tracked the amount of time spent engaging with the mobile health app and with the health coach.

    Time frame: At 3 months postpartum.

  4. mHealth Application Usage

    To assess intervention usage, the study team tracked logged tasks into the mobile health app.

    Time frame: At 3 months postpartum.

08

Results

Posted Nov 17, 2026

Participant flow

Participant flow — Overall Study
MilestoneDPP + Breastfeeding (Tx1)Usual Care
Started2221
Completed1720
Not completed51
Withdrew: Lost to follow-up41
Withdrew: Adverse event10

Outcome measures

PrimaryChange in Weight

The study team measured maternal weight at baseline, at delivery, and at 3 months postpartum to allow for meaningful comparisons of weight change among study arms.

Time frame:
At baseline and at delivery through 3 months postpartum
Reported as:
Mean · lbs
Change in Weight
lbsDPP + Breastfeeding (Tx1)Usual Care
Baseline - delivery (GWG)29.1 ± 20.436.0 ± 15.7
Baseline - 3 months postpartum (weight retention)3.2 ± 1611.0 ± 17.7
PrimaryMaternal Weight

The study team measured maternal weight at baseline, at delivery, and at 3 months postpartum to allow for meaningful comparisons of weight change among study arms.

Time frame:
At baseline and at delivery through 3 months postpartum
Reported as:
Mean · lbs
Maternal Weight
lbsDPP + Breastfeeding (Tx1)Usual Care
Pre-pregnancy weight (self-reported)177.9 ± 26.5179.2 ± 30.2
Weight prior to delivery (per hospital record)206.1 ± 32.6221.5 ± 30.5
Weight at 3 months postpartum177.1 ± 25.4191.1 ± 27.7
PrimaryDuration of Breastfeeding and Supplementation

The study team measured duration of breastfeeding and supplementation at day 3 postpartum and at specific timepoints through 3 months postpartum. Breastfeeding is defined as the feeding of human milk. The definition of "Exclusive Breastfeeding" is aligned with the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) and is as follows: the infant is fed only human milk and no other foods or fluids, not even water, except for oral rehydration solutions or drops/syrups of vitamins, minerals, or medicines. "Any Breastfeeding" is defined as the feeding of human milk supplemented with formula, water, etc. "Formula Only" is defined as the feeding of formula exclusively and no human milk.

Time frame:
At day 3, week 6, and 3 months postpartum.
Reported as:
Count of participants · Participants
Duration of Breastfeeding and Supplementation
ParticipantsDPP + Breastfeeding (Tx1)Usual Care
3 Days Postpartum — Exclusive breastfeeding1312
3 Days Postpartum — Any breastfeeding23
3 Days Postpartum — Formula Only23
6 Weeks Postpartum — Exclusive breastfeeding1012
6 Weeks Postpartum — Any breastfeeding34
6 Weeks Postpartum — Formula Only33
3 Months Postpartum — Exclusive breastfeeding911
3 Months Postpartum — Any breastfeeding35
3 Months Postpartum — Formula Only54
SecondaryEnrollment

To assess recruitment and enrollment rates, the study team tracked the number of potential participants contacted/screened versus the number of participants who were eligible to enroll and the number of participants who consented to enroll in the study.

Time frame:
This will occur between day 1 of the first participant screened to the study participant being randomized to one of two study arms.
Reported as:
Number · participants
Enrollment
participantsOne Group: All Study Participants
Number Screened125
Number Eligible of Screened73
Number Consented of Screened43
SecondarymHealth Application Engagement

To assess intervention uptake, the study team tracked the number of calls engaging with the mobile health app and with the health coach.

Time frame:
At 3 months postpartum.
Reported as:
Mean · attempts
mHealth Application Engagement
attemptsDPP + Breastfeeding (Tx1)
Number of successful antepartum contact attempts with health coach8.4 ± 2.8
Number of successful postpartum contact attempts with health coach9.2 ± 3.2
SecondarymHealth Application Engagement (2)

To assess intervention uptake, the study team tracked the amount of time spent engaging with the mobile health app and with the health coach.

Time frame:
At 3 months postpartum.
Reported as:
Mean · minutes
mHealth Application Engagement (2)
minutesDPP + Breastfeeding (Tx1)
Length of antepartum call minutes with health coach10.3 ± 4
Length of postpartum call minutes with health coach10.5 ± 5.1
SecondarymHealth Application Usage

To assess intervention usage, the study team tracked logged tasks into the mobile health app.

Time frame:
At 3 months postpartum.
Reported as:
Mean · logged tasks
mHealth Application Usage
logged tasksDPP + Breastfeeding (Tx1)
Physical activities logged in mHealt app2 ± 6.1
Meals logged in mHealth app19.6 ± 47.5
Maternal weight logged in mHealth app7.1 ± 4.8

Adverse events

Collected over Adverse event data were collected from the time of enrollment through 3 months postpartum follow-up.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
DPP + Breastfeeding (Tx1)0/22 (0%)1/22 (4.5%)0/22 (0%)
Usual Care0/21 (0%)0/21 (0%)0/21 (0%)
Most frequent serious events
Most frequent serious events
EventDPP + Breastfeeding (Tx1)Usual Care
MiscarriagePregnancy, puerperium and perinatal conditions1/220/21

Baseline characteristics

Age, Continuous
Age, Continuous(Years)DPP + Breastfeeding (Tx1)Usual CareTotal
Mean31.7 ± 6.528.1 ± 5.530 ± 6.2
Sex: Female, Male
Sex: Female, Male(Participants)DPP + Breastfeeding (Tx1)Usual CareTotal
Female222143
Male000
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)DPP + Breastfeeding (Tx1)Usual CareTotal
Non-Hispanic White111425
Non-Hispanic Black404
Non-Hispanic Asian101
Hispanic6713
Highest Level of Education Completed
Highest Level of Education Completed(Participants)DPP + Breastfeeding (Tx1)Usual CareTotal
Graduated from high school437
Some college3710
Graduated with an associate's degree202
Graduated with a bachelor's degree5712
Advanced degree (e.g., Master's, PhD, MD, JD)8412
Location
Location(Participants)DPP + Breastfeeding (Tx1)Usual CareTotal
Urban191130
Rural31013
Gross yearly total household income before taxes during the last 12 months
Gross yearly total household income before taxes during the last 12 months(Participants)DPP + Breastfeeding (Tx1)Usual CareTotal
$9,999 or less235
$10,000 to $24,999011
$25,000 to $49,9997815
$50,000 to $74,999044
$75,000 to $99,999505
$100,000 or more8513
Currently have health insurance
Currently have health insurance(Participants)DPP + Breastfeeding (Tx1)Usual CareTotal
Yes212041
No112
WIC participation during pregnancy
WIC participation during pregnancy(Participants)DPP + Breastfeeding (Tx1)Usual CareTotal
Yes10515
No121628

7 further baseline measures are reported on the registry.

09

Study locations

1 site
  • Via Christi Maternal Fetal Medicine Clinic
    Wichita, Kansas 67218, United States
10

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

11

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2024 to primary completion in Aug 2025, 16 months.

Results were first posted in Nov 2026, 1 year 2 months after primary completion.

Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's 16 months is below that.

Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 4, 2024
First posted
Apr 18, 2024
StartActual
Apr 30, 2024
Primary completionActual
Aug 31, 2025
CompletionActual
Aug 31, 2025
Results first posted
Nov 17, 2026
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Results
Results posted
posted Nov 17, 2026
Primary outcomes
2 edited, 1 added, 3 removed
What changed in the outcomes
  • EditedMaternal weightWeightTime frame: At baseline; at week 30, 32, and 34 of pregnancy; and at day 3, 10, week 3, 6, month 2 and month 3 postpartum. → At baseline and at delivery through 3 months postpartum
  • EditedDuration of LactationBreastfeeding and SupplementationTime frame: At delivery, discharge, at day 7, week 3, 6, month 1, 2, and 3 postpartum. → At day 3, week 6, and 3 months postpartum.
  • AddedChange in WeightTime frame: At baseline and at delivery through 3 months postpartum
  • RemovedMaternal body mass index (BMI)Time frame: At baseline; at week 30, 32, and 34 of pregnancy; and at day 3, 10, week 3, 6, month 2 and month 3 postpartum.
  • RemovedInitiation of LactationTime frame: At delivery.
  • RemovedType of Infant FeedingTime frame: At delivery, discharge, at day 7, week 3, 6, month 1, 2, and 3 postpartum.
Nov 17, 2026
Secondary outcomes
1 edited, 3 added, 4 removed
What changed in the outcomes
  • EditedMobilemHealth Application UsageTime frame: This will occur between day 1 of first participant enrollment through study completion, roughly 1-1.5 years. → At 3 months postpartum.
  • AddedEnrollmentTime frame: This will occur between day 1 of the first participant screened to the study participant being randomized to one of two study arms.
  • AddedmHealth Application EngagementTime frame: At 3 months postpartum.
  • AddedmHealth Application Engagement (2)Time frame: At 3 months postpartum.
  • RemovedRecruitment RateTime frame: This will occur between day 1 of first participant enrollment through study completion, roughly 1-1.5 years.
  • RemovedRetention RateTime frame: This will occur between day 1 of first participant enrollment through study completion, roughly 1-1.5 years.
  • RemovedResearch EngagementTime frame: After week 36 of pregnancy but prior to delivery, and after month 3 postpartum.
  • RemovedHealth Coach InteractionTime frame: This will occur between day 1 of first participant enrollment through study completion, roughly 1-1.5 years.
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    Results posted
    Primary outcomes 2 edited, 1 added, 3 removed
    What changed in the outcomes
    • EditedMaternal weightWeightTime frame: At baseline; at week 30, 32, and 34 of pregnancy; and at day 3, 10, week 3, 6, month 2 and month 3 postpartum. → At baseline and at delivery through 3 months postpartum
    • EditedDuration of LactationBreastfeeding and SupplementationTime frame: At delivery, discharge, at day 7, week 3, 6, month 1, 2, and 3 postpartum. → At day 3, week 6, and 3 months postpartum.
    • AddedChange in WeightTime frame: At baseline and at delivery through 3 months postpartum
    • RemovedMaternal body mass index (BMI)Time frame: At baseline; at week 30, 32, and 34 of pregnancy; and at day 3, 10, week 3, 6, month 2 and month 3 postpartum.
    • RemovedInitiation of LactationTime frame: At delivery.
    • RemovedType of Infant FeedingTime frame: At delivery, discharge, at day 7, week 3, 6, month 1, 2, and 3 postpartum.
    Secondary outcomes 1 edited, 3 added, 4 removed
    What changed in the outcomes
    • EditedMobilemHealth Application UsageTime frame: This will occur between day 1 of first participant enrollment through study completion, roughly 1-1.5 years. → At 3 months postpartum.
    • AddedEnrollmentTime frame: This will occur between day 1 of the first participant screened to the study participant being randomized to one of two study arms.
    • AddedmHealth Application EngagementTime frame: At 3 months postpartum.
    • AddedmHealth Application Engagement (2)Time frame: At 3 months postpartum.
    • RemovedRecruitment RateTime frame: This will occur between day 1 of first participant enrollment through study completion, roughly 1-1.5 years.
    • RemovedRetention RateTime frame: This will occur between day 1 of first participant enrollment through study completion, roughly 1-1.5 years.
    • RemovedResearch EngagementTime frame: After week 36 of pregnancy but prior to delivery, and after month 3 postpartum.
    • RemovedHealth Coach InteractionTime frame: This will occur between day 1 of first participant enrollment through study completion, roughly 1-1.5 years.
    + 2 other changes: verification date and description

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

12

Registry details

Key details

Study ID
NCT06372860
Responsible party
Lisette Jacobson (Associate Professor, Population Health, University of Kansas Medical Center) — Principal investigator
First posted
Apr 18, 2024
Start date
Apr 30, 2024
Primary completion
Aug 31, 2025
Completion
Aug 31, 2025
Results posted
Nov 17, 2026
Last update
Nov 17, 2026

Study contacts

Lisette Jacobson, PhD, MPA, MA
principal investigator · University of Kansas Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion